UPDATE.23

CATEGORIES

CPhI Innovations 1

Glass 2

Plastics 7

People 9

Worth a read 10

Web & Event 11

Customer NewsletterOctober 2017

Metal-free Gx RTF® glass syringe With the development of an innovative production technology registered for patent Gerresheimer created the new metal-free Gx RTF® glass syringe for sophisticated medications based on biotechnologically manufactured active ingredients. Page 2

Our Innovations for the CPhI Worldwide

Gx® InnoSafe™ – integrated, passive safety systemThe new Gx® InnoSafe™ syringe prevents unintentional needle stick injuries, excludes the possibility of accidental reuse and takes the needs of pharmaceutical companies and health care professionals equally into account. Page 2

Childproof Duma Pocket dispenserThe famous Duma Pocket tablet dispenser is now also available in a childproof design with a filling volume of 40 ml. It allows you to remove tablets and supplements discreetly. Page 8

TE-ring for eye-drop bottle now fixed in placeThe TE-ring for the authenticity protection on the type-A eye-drop bottle is now permanent-ly attached to the open bottle in accordance with the new requirements issued by the US Food and Drug Administration (FDA). The dimensions, properties and material remain unchanged. Page 8

Gx® Elite Glass VialsGx® Elite glass is made using type-I borosili-cate glass, and is 2–3 times harder than type-I standard glass. This makes it more resistant to breakage on the filling line and during lyophilization. Page 6

Sterile Gx® RTF Vials based on the Ompi EZ-fill® packaging processThe new Gx® RTF vials are washed, packaged in trays or nests and tubs, sterilized and then shipped to our customers in the pharmaceu-ticals industry. This enables our customers to start filling them straight away without the need for any intermediate process steps. Page 5

UPDATE.23

2 | OCTOBER 2017

GLASS CPHI INNOVATION

With their exposed cannulas, used syringes are an omnipresent source

of danger in doctor’s surgeries, labs, or hospitals. Existing needle

protection systems reduce the risk of injury for the user, but require

additional effort for filling on the part of the pharmaceutical

companies and with respect to the use of the syringe by healthcare

professionals. With Gx® InnoSafe™, Gerresheimer now offers a

syringe with an integrated and passive safety system that prevents

unintentional needle stick injuries, excludes the possibility of

accidental reuse and takes the needs of pharmaceutical companies

and health care professionals equally into account.

One careless movement is enough for health-care professionals to injure themselves on unprotected, used syringe cannulas or come into contact with aggressive active ingredients. In the most adverse case, this can result in serious infections. There is also a danger that already used syringes may accidentally be used a second time. Gx® InnoSafe™ provides reliable protection against needlestick injuries and eliminates the possibility of reuse. In con-trast with many existing solutions, the needle protection mechanism is thereby activated automatically and requires no further handling steps by the end user. This thus involves a so-called passive needle protection system. Also of advantage to the pharmaceutical com-panies is the processing of the Gx® InnoSafe™ syringes, which can take place on existing filling lines in the nested state without signif-icant changes. An additional assembly step of a safety system, as is usual on the market, is dispensed with.

The user wants to have a safety system which remains the injection process unchanged, ensures an intuitive and ergonomical handling

and does not require any additional operating steps for securing the cannula prior to dis-posal. The Gx® InnoSafe™ safety system is installed like a standard needle shield in the clean room on Gx RTF® glass syringes in the context of the manufacturing process. The syringe body is completely visible in order to be able to optimally see and check the pres-ence of the active agent, its purity and the administering. The injection itself is adminis-tered as usual. Following the removal of the ergonomic sealing cap with integrated flexible needle shield, the syringe is positioned at the injection point, the cannula inserted into the tissue and the active ingredient injected like with a conventional syringe. An accidental triggering of the safety system is prevented, as the mechanism isn’t preloaded prior to the injection. The system is first activated with the piercing of the cannula and then auto-matically ensures when removing the syringe from the injection point that the safety mech-anism is permanently locked. In this way, the cannula is reliably covered and reuse of the syringes is excluded.

Gx® InnoSafe™: optimal for pharmaceutical

companies and healthcare professionals

Gerresheimer presents an integrated

and passive safety system for the prevention

of needlestick injuries

UPDATE.23

3 | OCTOBER 2017

GLASS CPHI INNOVATION

Remove seal cap

1 4

2 5

3 6

Positioning of the safety system at the injection point

Insertion of the cannula into the injection point to the required piercing depth

Pushing of the piston rod to the end position

Removal of the syringe from the injection point

Safety system is activated without further handling of the consumer

Seal cap

with ergonomic grip surface

Spring

for fully automatic

locking

Gx RTF® needle syringes

Collar for a secure

connection to the RTF syringeTransparent sleeve

for optimal control

Flexible needle shield

Available in the conventional elastomers

for pharmaceutical applications

UPDATE.23

4 | OCTOBER 2017

Metal-free technology for residue-free cone shaping

One problem associated with syringe use is that traces of tungsten or other metals occasionally leave residue behind the bore when the syringe cone is shaped. Espe-cially for medications based on biotech-nologically manufactured active ingre-dients, the customers therefore require pre-fillable syringes that ideally exclude the possibility of contamination with me-tal. With the development of an innova-tive production technology registered for patent, Gerresheimer has been able to address this requirement and creates a metal-free 1 ml long Luer Lock Gx RTF syringe that is ready for series production. This process can also be transferred to other Luer Lock syringe sizes or to Luer cone syringes of various sizes at any time.

The pin used to shape the cone with the new technology isn’t made of conventi-onal tungsten or an alternative metal, but of a special ceramic. External studies con-firm that Gerresheimer can manufacture residue-free syringes for the packaging of especially sophisticated medications with this new technology. The Fresenius Insti-tute conducted a study confirming that no ceramic residue can be detected in the syringe. A biocompatibility study also ve-rifies the non-cytotoxicity of the ceramic material.

GLASS CPHI INNOVATION

For the pharmaceutical company, Gx® In-noSafe™ offers advantages for the filling process of ready-to-fill syringes. The safety system is installed fully automatically like a standard needle shield in the clean room onto Gx RTF® glass syringes and checked to 100 percent by visual inspection for potential nee-dle piercing and safety system position. The syringes are then packaged, sealed and ster-ilized with ethylene oxide gas including the safety system in a 100 hole tray (nest) and in a tub. They can be processed on existing fill-

ing lines without additional preparation and assembly steps. The design of the safety mech-anism ensures that unintended activation while filling, packaging, and transport is avoided. The flexible needle shield is available in all customary available elastomers for phar-maceutical applications. With the introduction of the new product line Gx® InnoSafe™ is available for the 1.0 ml long Gx RTF® glass syringe with a ½" cannula. Additional syringe variants will follow.

UPDATE.23

5 | OCTOBER 2017

Two manufacturers – one packaging

Gerresheimer’s two areas of expertise – the glass forming of vials from tubular glass and the ready-to-fill processing of pre-fillable glass syringes – will also be combined with recog-nized Ompi EZ-Fill packaging technology for the new Gx® RTF vials. The Gx® RTF vials are washed, packed in trays or in nests and tubs and sterilized before being delivered to phar-maceutical customers. They can then be filled straight away without the need for any further steps in the process.

“Our new injection vials meet our customers’ increasing desire for comprehensive solutions. Together with Ompi, we are taking a step closer to establishing a standardized platform for sterile vials. In doing so we are radically simplifying the process for the customers,” says Andreas Schütte, Member of the Man-agement Board for Plastics & Devices at Ger-resheimer.

Flexibility through various packaging configurations

The new product currently exists in the 2R, 6R, 10R, 20R formats in nests and tubs as well as in formats ranging from 2 to 30 ml in tray. Further formats will follow. The new packaging solution allows the vials to be used from the development phase of new medi-cations to small or large-scale production.

In hall 4.2 at booth D02 at CPhl Worldwide in Frankfurt, Gerres-

heimer, a leading global manufacturer of primary packaging for the

pharmaceutical industry is presenting the new Gx® RTF vials. The

customer can receive identically packaged sterile injection vials from

two different manufacturers as Gerresheimer’s RTF vials will be

delivered adopting Ompi EZ-fill® packaging process.

Maximilian VoglProduktmanager Injection Devices

Wednesday, 25th October 201713:50 p.m.

CPhI WorldwideMesse Frankfurt, Frankfurt, Germany

Enhanced flexibility for packaging requirements: Ready-to-fill vials

Gx® RTF vials powered by Ompi EZ-fill® enhance flexibility by facilitating packag-ing needs from clinical stage to industri-alization with the common goal to mini-mize customer product risks and optimize total cost of ownership. Gerresheimer combines the competencies in converting glass tubes to serum/injection vials and transforming bulk into ready-to-fill prod-ucts for our pharma and biotech custom-ers. Gx® RTF vials are a sterile primary pack-aging solution delivered ready-to-fill in nest and tub or tray according to estab-lished packaging configurations for more flexibility during fill & finish processes.

“We are very happy that Gerresheimer is adopting our leading technology. Our scalable solution gives the customer more flexibility, enhances quality and safety, and reduces time to market”, says Mauro Stocchi, General Man-ager Pharmaceutical Systems Division of the Stevanato Group.

Top quality requirements

The Gx® RTF injection vials are made from borosilicate glass type I. They meet all estab-lished requirements of the applicable ISO standards and pharmacopoeias (USP and Ph. Eur.). By using the Ompi EZ-fill packaging formats, the risk of glass-to-glass contact, which could result in breakages, cosmetic defects, and particle contamination is mini-mized.

PharmaCompany

Converting Washing Packaging Sterilization Fill and Finish

Gx® RTF Prozess powered by

Gx® RTF Vials: ready-to-fill

vials from Gerresheimer

GLASS CPHI INNOVATION

EXPERT LECTURE

UPDATE.23

6 | OCTOBER 2017

The Gx® Elite vials have set new standards for type 1 borosilicate glass vials. They are the result of comprehensive optimization measu-res in the conversion process, which have focused on designing out the risk to create product flaws during production including the removal of all glass-to-glass contact be-ginning with the tubing material all the way through final packaging. The chemical com-position of the borosilicate glass is still the same. Gerresheimer will be showcasing Gx Elite vials at booth D02 in Hall 4.2 at CPhI Worldwide in Frankfurt (Germany) from October 24 to 26, 2017.

The best in its class

“Our Gx® Elite vials are setting new standards when it comes to quality,” says Jens Heymann, Senior Vice President Europe & Asia Tubular Glass at Gerresheimer, underlining the major difference that avoiding glass-to-glass contact in the production process can have on vial quality. The highly shatter-resistant vials are extremely durable and free of cosmetic de-fects. They also boast an incredibly robust structure, while their resistance to delamina-tion protects the drug inside. Simple handling and a range of packaging options ensure that Gx® Elite vials can be supplied for end-to-end use on various filling lines. For customers, this means lower costs and higher quality.

Gx® Elite Vials are a step up from standard products,

performing significantly better in compression and side impact tests.

Intelligent defect recognition

All of Gerresheimer’s tubular glass plants that produce vials work with standardized moni-toring, inspection, and packaging technolo-gies, which essentially comprise the Gx® G3 and Gx® RHOC systems. The inspection sys-tems are developed in-house and form part of a close-knit testing system that ensures the highest precision and quality assurance in line with the latest standards. Complete with five HD cameras, the Gx® G3 inspection system makes sure that cosmetic defects are identified reliably, for instance. The intelligent software detects and classifies the defects in a few

Gx® Elite Vials: Perfect injection vials presented by Gerresheimer

fractions of a second, while the Gx® RHOC system ensures dimensional quality with three HD matrix cameras on each side and a hyper-centric ID camera. Injection vials set the benchmark for primary packaging for parenteral drugs. Gerresheimer’s vials come in all sizes and comply with the relevant international standards and pharma-copoeias (EU, USP, JP). The range includes solutions for bioengineered drugs and other specialist pharmaceuticals.

GLASS CPHI INNOVATION

Gx® Elite

Standard

Sidewall Impact Testing

80

60

40

20

0

% S

urv

ival

Impact Setting4.7 inch-lbs

Horizontal Load(Average)

Compression Testing

Vertical Load(Median)

800

600

400

200

0

Load

(Ib

s)

UPDATE.23

7 | OCTOBER 2017

As a specialist in plastic packaging for the pharmaceutical industry, Gerresheimer Plastic Packaging (GPP) offers a wide range of pack-aging solutions for solid, liquid, and opthamo-logical products. Included in our comprehen-sive and innovative product range are our leading brands Duma®, Dudek™ and Triveni for solid dosage forms, our PET bottles by the brand edp for liquid dosage forms, as well as our products for opthamological applications. Our diversified standard range incorporates

Valor™ Glass is a breakthrough glass contai-ner engineered for the storage and delivery of 21st century injectable drugs. Valor™ Glass is an unprecedented improvement in glass container quality. Valor™ Glass’s superior strength, chemical durability and damage resistance result in better protection for drug products. Valor™ Glass also enables increased throughput and higher levels of quality assu-rance for pharmaceutical companies, and higher-quality medicines for patients.

Corning and Gerresheimer have been working together since 2015 to accelerate Corning innovations for the pharmaceutical glass pa-ckaging market.

“We are thrilled to be working with Corning on innovations to enhance quality across the industry. Valor Glass is a remarkable glass with outstanding performance on every attribute and meets USP Type 1 hydrolytic criteria“, said Jens Kürten, Group Senior Director Com-munication & Marketing at Gerresheimer.

“Gerresheimer is a long-standing leader in the industry. They’ve been a terrific collabo-ration partner, and we’re excited to be wor-king with them to bring Valor™ Glass to the pharmaceutical industry,” said Ron Verkleeren, Vice President and General Manager, Corning Pharmaceutical Technologies.

Closer to the customer:

Gerresheimer Plastic Packaging gets production underway in the U.S.

Corning and Gerresheimer Collaborate to Deliver New Corning Valor™ Glass to the Pharmaceutical Packaging MarketRemarkable glass innovation enables enhanced quality parenteral packaging

Corning Incorporated (NYSE: GLW) and Gerresheimer announce that they are accelerating the supply of Corning Valor™ Glass to the pharmaceutical industry.

GLASS CPHI INNOVATION

PLASTICS

all manner of different containers and clo-sures, PET bottles, eye drops, nasal sprays, and vaporizers as well as countless custom-er-specific developments.

GPP is now expanding its global presence further and is assuming responsibility for the clean room production of plastic bottles in the U.S. state of Ohio at its sister com-pany Centor in Berlin.

Valor™ is a pending trademark of Corning Inc.

UPDATE.23

8 | OCTOBER 2017

High-speed filling

The Duma® Pocket containers can be filled at high speed, packed without taking up much room, and stored with ease. Besides the two new Duma® Pocket designs we have an ex-isting Duma® Pocket in 30 ml and 50 ml with a TE-function. All three designs can be ex-tended to different sizes using the same base.

PLASTICS CPHI INNOVATION

It is often only the minor improvements that make a product ideal to use. The TE-ring fixed to the type A eye-dropper bottle in accordance with the new FDA regulations is one good example.

The US Food and Drug Administration (FDA) now stipulate that the TE-ring must be firm-ly attached to the bottle. This product change was very easy to make, owing to experience with the type B dropper bottle, which already has a fixed TE-ring. Only minor adjustments were made to the design, while the dimen-sions, properties, and the materials are the same. The bottle and the dropper are made

from LDPE and the cap from HDPE. The ex-isting type A dropper bottles can therefore be used for stability tests.

Production of US dropper bottles with a fixed TE-ring will be operational in Q3, 2017 and production will besides Poland also be pro-duced out of both India and US.

Gerresheimer produces type A dropper bottles holding 2–360 ml under clean-room condi-tions. Depending on the size of the contain-er, they are produced using the injection blow molding (IBM) or the extrusion blow molding (EBM) process. Radiation or ETO sterilization

Gerresheimer presents handy solutions for plastic primary packaging

Patients prefer pharmaceutical packaging that does not give away its contents at first glance. With their oval shape, Gerresheimer’s extreme-ly handy Duma® Pocket containers look more like boxes of sweeteners, chewing gum, or peppermints. The Duma® Pocket is available in many different sizes and colors and with various closures. Gerresheimer is expanding its range of this tried-and-tested packaging with the addition of the 40 ml Duma® Pock-et CR Box and the 100 ml Duma® Pocket CR 100 for large filling volumes.

The 40 ml Duma® Pocket CR Box has a child-proof closure, which can be opened by ap-plying moderate pressure to the sides of the box with one hand while opening the top with the other: a simple task for adults but not for tiny hands.

As the name suggests, the Duma® Pocket CR 100 can hold up to 100 ml. It also boasts an

TE-ring now firmly attached to the dropper bottle in line with FDA requirements

ergonomic design, a simple dispensing system, a childproof closure, and mounted desiccant(s) stored in its base. These impressive features make it an ideal primary packing solution for all kinds of drugs that need to be taken every day.

Lots of space for branding

The sides of the Duma® Pocket boxes are a perfect place for consumer information and offer plenty of room for distinctive brand de-signs, while the top area can be labeled indi-vidually for each client.

Available in every color

The Duma® Pocket containers can be produced in any color and can even be made translucent or transparent. They are injection-moulded under clean room conditions.

Duma® Pocket – the pharmaceutical packaging that doesn’t look like medicine

is possible on request. All caps protect the original contents and can also be supplied with a child-proof screw cap.

UPDATE.23

9 | OCTOBER 2017

PLASTICS PEOPLE

Dr. Christian Fischer

Dr. Christian Fischer has been a member of the Management Board of Gerres-heimer AG since August 2017.

He joined BASF in 1993. Having started his career as a laboratory team leader, he went on to be Deputy Division Manager, Global Marketing Director, and Sales Di-rector in different plastic divisions. As Group Vice President, Fine Chemicals Asia Pacific based in Hong Kong from 2004 to 2008, he was responsible for the produc-tion and marketing of products for the pharma, cosmetics, aroma, animal, and human nutrition industries. Between 2008 and 2014, he was as President responsible for BASF SE’s global materials and systems research. As President Performance Chem-icals from 2015 to March 2017, he held overall responsibility for plastic additives, fuel and lubricant additives as well as chemicals for the mining, oilfield, water, paper, and leather industry.

Christian Fischer holds a diploma degree in Chemistry (University of Regensburg) and a PhD in the same subject. He also has a degree in Business Administration (VWA Mannheim). He was appointed honorary professor at the Technical Uni-versity of Munich (TUM) in 2014.

With effect from Sep-tember 1, 2017, Dr. Christian Fischer (53) assumed responsibility as Chief Executive Of-ficer of Gerresheimer AG. He succeeds Uwe Röhrhoff (55), who left the company as of Au-

gust 31, 2017. Christian Fischer joined the Management Board as a regular member on August 1, 2017, having previously been Pres-ident Performance Chemicals at BASF SE in Ludwigshafen, where he spent 24 years.

“The Supervisory Board would like to thank Uwe Röhrhoff for the outstanding work he has done for Gerresheimer AG. In his 26 years at Gerresheimer, including seven as CEO, he played a key role in determining the compa-ny’s strategic focus as well as in securing major acquisitions, reshaping the corporate portfolio, and delivering operational projects. In other words, he has been instrumental in the success that Gerresheimer currently en-joys. We would like to wish Uwe Röhrhoff all the best in his professional and personal en-deavors. We have found an exceptional suc-cessor in Christian Fischer, who has demon-strated excellent leadership skills and brings many years of industry experience. Together with him we are looking forward to continue driving Gerresheimers future success,” said Dr. Axel Herberg, Chairman of the Supervi-sory Board of Gerresheimer AG

Dr. Christian Fischer succeeds Uwe Röhrhoff as CEO of Gerresheimer AG

As of September 01, 2017 Stefan Verheyden took over two func-tions: He is Global Vice President Gx® Solutions and at the same he is Global Vice President Sales Syringes, both in the Business Unit Medi cal Systems.

In his first function he leads the new unit Gx® Solutions, which takes care of solutions and products for the special needs of pharma

customers who develop and sell biotech drugs. This includes the development of innovative system solutions made of glass and plastics as well. Gx® Solutions is part of the Business Unit Medical Systems (MDS). In his second function he leads the existing sales team for syringe systems.

Stefan Verheyden worked as Senior Vice Pres-ident Sales Pharma Packaging International at Nipro Pharma Packaging before. Prior to that he was Director of Sales EMEA Global Pharmaceutical Solutions / Drugs & Devices with the Terumo Corporation.

Plastics & Devices

Stefan Verheyden new Global Vice President Gx® Solutions and Global Vice President Sales Syringes

50 years of Duma® Standard

The renowned 50 ml Duma®

Standard container has

now been on the market

for 50 years. Production of

this successful model began

in 1967 at Gerresheimer

Vaerloese (Denmark) when

it was the first HDPE con-

tainer in the world to be

used for solid pharmaceuti-

cal ingredients. Nowadays

HDPE is the prevailing

standard for solid goods in

the pharmaceutical sector

for solid goods.

The Duma® Standard con-

tainer has long since ceased

to be in use in the field of

pharmaceuticals alone. It is

also popular in the consum-

er goods sector e.g. for

vitamins, food supplements,

and chewing gum and is

available in many sizes and

colors.

UPDATE.23

10 | OCTOBER 2017

well as HR. Andreas Kohl is responsible for Operations, Technics, Quality and Operation-al Excellence. Paul Wienen joined Gerres-heimer in November 2016 coming from 3M. Andreas Kohl has been working for Gerres-heimer since 1994.

WORTH A READ

Injectable Drug Delivery: New Technologies Deliver Biologics and Differentiate Brands Drug Development & Delivery, September 2017, Vol. 17, No. 6, page 72–88.

increasing use of biologics, a rise in the prevalence of chronic diseases, increasing occurrence of needlestick injuries, and the benefits of injections are increasing the demand for safety syringes, prefilled syringes, and autoinjectors.

This year’s Drug Development & Delivery Injectable Device Report showcases the features of newly developed, and soon-to-be-commercialized technologies that address the issues of ease of use, high viscosity delivery, and brand differentiati-on.

Metall-free Methods Pharmaceutical Manufacturing Packaging Sourcer, August 2017, page 20-22, Bernd Zeiss (Gerresheimer Bünde GmbH)

Tungsten residuals can potentially interact with the drug product when remaining in pre-filled syringes. Glass manufacturers have developed technologies to avoid these.

PEOPLE

Plastics & Devices

Lars Priess has been appointed Vice President Sales & Business Development Asia Primary Packaging

Lars Priess has been ap-pointed as Vice President Sales & Business Develop-ment Asia Primary Pa-ckaging for accelerating our growth and market development in Asia. He

operates from the new office in Singapore, which was opened on September 1, 2017.

Primary Packaging Glass

Edward Troy has been appointed as Vice President Sales & Marketing North America Primary Packaging Glass

Edward Troy has been ap-pointed as Vice President Sales & Marketing North America Primary Packaging Glass effective from June 5, 2017. Edward has over 25 years of experience in

pharmaceutical sales and sales management, having worked for R.P. Scherer (Catalent) and FMC Corporation. In his most recent function he worked as Senior Director of Sales, North America at West Pharmaceutical Services in the USA.

Primary Packaging Glass

Benedict J. Scheu has been appointed as Senior Vice-President Centor and President Centor Inc.

Benedict J. Scheu has been appointed as Senior Vice President Centor and Presi-dent Centor Inc. in Perrys-burg and Berlin, Ohio, USA, effective from July 1, 2017. Benedict J. Scheu began

his career in plastics packaging Sales, moved into Product Development and moved into in-creasingly technical Sales roles and P&L accoun-tability. Before joining Gerresheimer, Ben held the position of Chief Operating Officer at The Waddington Group in Covington, Kentucky, USA. Prior to that he was President, Thompson Oak Partners, Nashville, Tennessee, USA.

Paul Arsenault, Senior Vice President Centor and President Centor Inc., will retire by De-cember 31, 2017. From June 12 until July 1, Paul Arsenault will transition his responsibi-lities as President to Ben. From July 1 to the end of December, Paul Arsenault will work on dedicated projects and further assist Ben in his transition.

Walther Geiger has been appointed as Plant Director Küssnacht Medical Sys-tems, Switzerland, effec-tive from August 1, 2017. Walther Geiger has 20 years of experience in pro-

duction. Before joining Gerresheimer he held the position of Manager Production & Man-ager Process Engineering at TE Connectivity Solutions GmbH in Wohlen, Switzerland. Prior to that he worked for Synthes Hägendorf GmbH in Hägendorf, Switzerland.

Plastics & Devices

Walther Geiger has been appointed as Plant Director Küssnacht Medical Systems

As of May 15, 2017 Paul Wienen, Global Senior Vice President Sales, Resource Planning & Administration, and Andreas Kohl, Global Senior Vice President Operations, Technics & Quality, took over leadership for the Business Unit Moulded Glass following Bruno Bürkel.

Paul Wienen is the Chairman of the Business Unit and responsible for Sales, Finance & Con-trolling, Resource Planning, Purchasing, IT as

Primary Packaging Glass

New Leadership of Business Unit Moulded Glass

UPDATE.23

www.gerresheimer.com

WEB & EVENT

OCTOBER 24– 26, 2017 CPhI WorldwideFrankfurt, Germany Messe Frankfurt | Booth 4.2 D02

NOVEMBER 07– 08, 2017 The Universe of Pre-filled Syringes and Injection Devices (PDA)Vienna, Austria Austria Center | Booths 93 & 94

NOVEMBER 13– 16, 2017 Compamed / MedicaDüsseldorf, Germany Messe Düsseldorf Hall 8a, Booth P33

NOVEMBER 21– 24, 2017Pharmtech & IngredientsMoscow, RussiaCrocus Expo IEC

NOVEMBER 28– 30, 2017CPhI IndiaMumbai, India Bombay Exhibition Centre | Booth C87

FEBRUARY 06– 08, 2018 MD&M WestAnaheim, USA Anaheim Convention CenterBooth 2572

FEBRUARY 07– 08, 2018 Pharmapack EuropeParis, Frankreich Paris Expo Porte de Versailles Booths A20 & A24

FEBRUARY 08– 10, 2018 Asia Pharma Expo DhakaBangladesh | International Convention City Bashundhara (ICCB)

GERRESHEIMER

EVENT-CALENDAR

MARCH 27– 28, 2018 PDA Europe Parenteral PackagingPrag, Czech Republic

MARCH 19– 22, 2018 DCAT WeekNew York, USA

MARCH 19– 20, 2018 PDA Annual MeetingOrlando, USA Loews Sapphire Falls ResortBooth 518

MARCH 27– 29, 2018 CPhI South East AsiaJakarta, Indonesia Jakarta International Expo

In June 2017, a new showroom was opened at our plastics factory in the Danish town of Vaerloese, which showcases the company and its products effectively with modern displays. The bright, glass-domed hall boasts a number of movable displays with numerous pictures and short descriptions presenting key infor-mation on how the company began, its are-as of production expertise, and the locations of all the GPP sites.

The showroom is split into two areas with different customized elements. In the first area, the displays tell the story of Dudek Plast,

New Showroom at Gerresheimer Vaerloese (Denmark)

how Duma became a globally recognized brand, and how the production team works to produce top quality with a “zero defect approach,“ and offer an introduction to all the GPP production sites.

This is complemented by a plethora of cabinets that contain samples of the broad product range for visitors to look at and touch. There is also a board illustrating the most important innovations of the last 50 years. All the ele-ments are versatile, play specific roles, and can be upgraded at any time at low cost.

2017 / 2018

Imprint: © Design and editing Gerresheimer Group Communication & MarketingKlaus-Bungert-Straße 4 | 40468 Düsseldorf, Germany Jens Kürten | Phone: +49 211 6181-250 | Fax: +49 211 6181-241 | j.kuerten@gerresheimer.comDr. Cordula Niehuis | Phone: +49 211 6181-267 | Fax: +49 211 6181-28 267 | c.niehuis@gerresheimer.comMarion Stolzenwald | Phone: +49 211 6181-246 | Fax: +49 211 6181-28 246 | m.stolzenwald@gerresheimer.com

Improvedproduct searchThe Products tab on our website presents all our glass and plastics products clearly so that you can find your way straight to the relevant product group. Delving a lit-tle deeper, you can access our interactive online catalog in just a few steps or find detailed information about all our prod-ucts and services. If you want to search for specific article numbers or names, you will now find a new full-text search with auto-complete on the product pages, which allows you to quickly view the re-quired articles from the online catalog.

www.gerresheimer.com

Gx® InnoSafe™ Integrated Safety System

| Protection against needlestick injuries

| Eliminates the possibility of reuse

| Fully passive safety function:

protection mechanism is activated

automatically – no additional actions required

| Fully integrated system:

delivered pre-assembled in nest and tub